SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently trending following a significant $816 million contract award to build 18 missile-defense satellites for the U.S. Space Force, marking its largest deal to date. This substantial win has fueled intense community discussion about its growing role in the space and defense sector, with many anticipating further upside from upcoming catalysts like the Neutron rocket and the broader momentum in space stocks. Sentiment suggests strong conviction that this contract validates Rocket Lab's position alongside larger prime contractors and could trigger short-covering activity.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending as political discourse intensifies around healthcare costs, with public statements calling for insurance companies to reduce prices. The community is actively debating the potential for a market impact, with some anticipating declines for the sector while others view the rhetoric as political maneuvering that could still lead to long-term benefits for diversified players like UNH. Additional discussions include the potential implications of ongoing talks about ACA subsidies and the company's recently adopted operational improvements following independent audits.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines (LUNR) is trending due to a positive analyst rating from KeyBanc and mounting anticipation for a key NASA Lunar Terrain Vehicle (LTV) contract award. The community is actively discussing the potential for a short squeeze, viewing LUNR as a front-runner in the heating up space exploration sector. This sentiment, bolstered by broader governmental focus on American space superiority, is driving significant trading volume.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is experiencing a strong rally, largely attributed to its selection for a U.S. Department of Energy initiative and a renewed 'Buy' rating from analysts. The community is actively discussing a massive short squeeze, with many expressing strong bullish conviction about its strategic importance in the rapidly expanding AI infrastructure sector.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending following its proposed merger with a nuclear fusion company, dramatically shifting its business focus into the speculative energy sector. This pivot is driving intense debate among investors, with supporters touting it as a visionary move for energy independence and significant future growth, while skeptics warn of substantial dilution and question the viability of merging a social media platform with a pre-revenue technology venture. The discussion is further amplified by broader political discourse, contributing to high volatility and strong polarization in community sentiment surrounding the stock.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire Corp is experiencing heightened trading activity and surging volume, propelled by a significant new contract for spacecraft docking systems and its pivotal role in critical space infrastructure. The community is buzzing with optimism about the company's prospects in the expanding space economy, driven by narratives around in-space data centers, defense initiatives, and potential short-squeeze dynamics.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network ($ZBCN) is trending as the community eagerly anticipates confirmed ISO 20022 compliance and the launch of its Super App, alongside recent strategic partnerships with entities like NatPay, Fasset, and Dash. Discussions highlight Zebec's foundational work in real-time compliant payments, leading many to accumulate and stake tokens. This robust development in payment infrastructure and global utility is driving comparison to established compliant digital assets, with community members expressing strong conviction for significant long-term growth despite observed market fluctuations.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending on strong bullish sentiment driven by the imminent BlueBird 6 satellite launch and anticipation of an expedited launch schedule, with multiple subsequent launches planned. The community is also highly focused on the recent signing of the Golden Dome defense bill, which is expected to unlock significant government contracts for commercial space solutions and is seen as a major catalyst for the company and the broader space sector.

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

Novabay Pharmaceuticals Inc

Novabay Pharmaceuticals is trending with intense trading activity, driven by a recent analyst "buy" rating and an upcoming special cash dividend. Community discussion is focused on the company's hinted pivot towards blockchain-based assets and its historically high short interest, contributing to significant volatility and mixed sentiment.

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator, CK-136, a novel cardiac troponin activator, reldesemtiv, a novel fast skeletal muscle troponin activator, aficamten, a novel cardiac myosin inhibitor, and CK-3772271, a novel cardiac myosin inhibitor. The company was founded by Ronald D. Vale, Lawrence S. B. Goldstein, James H. Sabry, and James A. Spudich in 1997 and is headquartered in South San Francisco, CA.

Cytokinetics Inc

Cytokinetics is trending following the FDA approval of MYQORZO (aficamten) for symptomatic obstructive hypertrophic cardiomyopathy, a groundbreaking treatment that has ignited significant community discussion. Investors are highlighting its favorable REMS program and differentiated profile compared to existing therapies, positioning it as a potential new standard of care in the sector. This pivotal regulatory milestone continues to fuel ongoing speculation regarding potential future acquisition interest in the company.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Envestnet Asset Management Inc. Sells 98,195 Shares of Fortress Biotech, Inc. $FBIO

Envestnet Asset Management Inc. lessened its holdings in Fortress Biotech, Inc. (NASDAQ:FBIO - Free Report) by 36.7% during the second quarter, according to its most recent 13F filing with the...

Fortress Biotech (NASDAQ:FBIO) Upgraded at Wall Street Zen

Wall Street Zen upgraded Fortress Biotech from a "hold" rating to a "buy" rating in a report on Sunday...

Fortress Biotech (NASDAQ:FBIO) Issues Earnings Results

Fortress Biotech (NASDAQ:FBIO - Get Free Report) announced its quarterly earnings results on Friday. The biopharmaceutical company reported $0.11 earnings per share (EPS) for the quarter, beating the...

Fortress Biotech (NASDAQ:FBIO) Rating Lowered to Hold at Wall Street Zen

Wall Street Zen downgraded Fortress Biotech from a "buy" rating to a "hold" rating in a report on Saturday...

Fortress Biotech (NASDAQ:FBIO) Stock Crosses Above Two Hundred Day Moving Average - Here's What Happened

Fortress Biotech (NASDAQ:FBIO) Shares Cross Above 200-Day Moving Average - Should You Sell...

Fortress Biotech (FBIO) Surpasses Q3 Earnings Estimates

Fortress Biotech (FBIO) delivered earnings and revenue surprises of +125.58% and -25.55%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Armata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Misses Revenue Estimates

Armata Pharmaceuticals (ARMP) delivered earnings and revenue surprises of 0.00% and -16.01%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Kamada (KMDA) Misses Q3 Earnings Estimates

Kamada (KMDA) delivered earnings and revenue surprises of -10.00% and +1.64%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Prothena (PRTA) Reports Q3 Loss, Lags Revenue Estimates

Prothena (PRTA) delivered earnings and revenue surprises of -11.67% and -90.26%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Ultragenyx (RARE) Reports Q3 Loss, Misses Revenue Estimates

Ultragenyx (RARE) delivered earnings and revenue surprises of -47.15% and -4.55%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.

FBIO
Fortress Biotech Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FBIO News

FBIOFortress Biotech Inc